Chris has over three decades of executive leadership experience in the healthcare and medical technology sectors and served on Laborie’s Board of Directors for two years before becoming President & CEO in 2025. Prior to joining Laborie, Chris served as CEO of NeoGenomics Laboratories, Ortho Clinical Diagnostics, and Cochlear Limited, where he led transformative growth and innovation. He has also held several board positions across both private and public companies. He has a proven record of leading global, customer-focused teams to drive growth, improve margins, and execute strategic priorities and is passionate about building a culture rooted in patient/customer centricity and high performance.